Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cel-Sci Corporation Common Stock (NY:CVM)

1.010 UNCHANGED
Streaming Delayed Price Updated: 9:53 AM EDT, Jun 16, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cel-Sci Corporation Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
CEL-SCI Corporation (NYSE:CVM) Investor Investigation over Potential Wrongdoing ↗
San Diego, CA -- (SBWIRE) -- 09/07/2021 -- Certain directors of CEL-SCI Corporation are under investigation over potential breaches of fiduciary duties. 
Via SBWire
News headline image
Mid-Day Market Update: monday.com Jumps Following Strong Q2 Results; Kubient Shares Plunge ↗
Midway through trading Tuesday, the Dow traded down 0.81% to 35,336.88 while the NASDAQ fell 0.89% to 14,661.86. The S&P also fell, dropping 0.65% to 4,450.54. The U.S. has... 
Via Benzinga
Topics Stocks
News headline image
CEL-SCI Corporation Reports Third Quarter Fiscal 2021 Financial Results
From CEL-SCI Corporation
Via Business Wire
Analyzing CEL-SCI's Unusual Options Activity ↗
On Tuesday, shares of CEL-SCI (AMEX:CVM) saw unusual options... 
Via Benzinga
News headline image
Understanding CEL-SCI's Unusual Options Activity ↗
CEL-SCI (AMEX:CVM) shares experienced unusual options activity on Monday. The stock price moved down to $7.68 following the option alert. Sentiment: NEUTRAL Option Type: TRADE... 
Via Benzinga
Why CEL-SCI Shares Are Getting Hammered Today ↗
CEL-SCI Corporation (NASDAQ:CVM) shares are trading lower b... 
Via Benzinga
News headline image
CEL-SCI Corporation (NYSE:CVM) Shareholder Notice: Investigation over Possible Violations of Securities Laws ↗
San Diego, CA -- (SBWIRE) -- 07/13/2021 -- CEL-SCI Corporation is under investigation concerning potential securities laws violations in connection with certain financial statements. 
Via SBWire
News headline image
Unusual Options Activity Insight: CEL-SCI ↗
Shares of CEL-SCI (AMEX:CVM) saw some unusual options activity on Monday. Following the unusual option alert, the stock price moved up to $9.35. Sentiment: BEARISH Option Type:... 
Via Benzinga
News headline image
Why CEL-SCI Stock Soared Today ↗
The company attempted to clarify "confusion" related to its recent late-stage clinical results. 
Via The Motley Fool
News headline image
CEL-SCI Corporation Issues Letter to Shareholders
From CEL-SCI Corporation
Via Business Wire
News headline image
3 Biotechs to Avoid Like the Plague in July ↗
Generally speaking, biotech is a pretty innovative industry -- with a few notable bad apples. 
Via The Motley Fool
News headline image
Discussion of Results of CEL-SCI’s Phase 3 Trial Is Now Available
From CEL-SCI Corporation
Via Business Wire
News headline image
Stocks That Hit 52-Week Lows On Friday ↗
Before 10 a.m. ET on Friday, 43 companies set new 52-week lows. Points of Interest: Autohome (NYSE:ATHM) was the largest firm by market cap to set a new 52-week low... 
Via Benzinga
News headline image
CEL-SCI to Conduct Investor Call Regarding Phase 3 Results Following Annual Shareholder Meeting on July 1, 2021
From CEL-SCI Corporation
Via Business Wire
News headline image
72 Biggest Movers From Yesterday ↗
Gainers Pop Culture Group Co., Ltd (NASDAQ: CPOP) shares jumped 405% to close at $30.30 on Wednesday after the company priced its IPO at $6 per share. Cuentas Inc. (NASDAQ: CUEN... 
Via Benzinga
Topics Initial Public Offering
News headline image
Will All End Well for This Popular Reddit Biotech? ↗
Everything went the wrong way for Cel-Sci. 
Via The Motley Fool
News headline image
51 Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers Cuentas Inc. (NASDAQ: CUEN) shares jumped 176.6% to $7.69. The stock spiked following a press release saying "WaveMax to Implement the World's First Shared Wifi6... 
Via Benzinga
News headline image
Mid-Afternoon Market Update: Nasdaq Gains 100 Points; New Senior Investment Shares Spike Higher ↗
Toward the end of trading Monday, the Dow traded down 0.49% to 34,266.49 while the NASDAQ rose 0.72% to 14,463.26. The S&P also rose, gaining 0.05% to 4,283.04. The U.S. has... 
Via Benzinga
Topics Stocks
News headline image
60 Biggest Movers From Yesterday ↗
Gainers Marin Software Incorporated (NASDAQ: MRIN) surged 96.9% to close at $7.50. Marin Software, last week, announced it has added the ability to manage Instacart Ads to its... 
Via Benzinga
News headline image
Nasdaq Hits Intraday Highs as Treasury Yields Retreat ↗
The Dow Jones Industrial Average is 216 points lower at midday, erasing this morning's marginal gains amid growing pressures on energy and transportation stocks. 
Via Talk Markets
Topics Stocks
News headline image
Mid-Day Market Update: Crude Oil Down Over 1%; Intellia Therapeutics Shares Jump ↗
Midway through trading Monday, the Dow traded down 0.52% to 34,253.86 while the NASDAQ rose 0.72% to 14,463.56. The S&P also fell, dropping 0.01% to 4,280.50. The U.S. has the... 
Via Benzinga
Topics Stocks
News headline image
44 Stocks Moving In Monday's Mid-Day Session ↗
Gainers Intellia Therapeutics, Inc. (NASDAQ: NTLA) shares climbed 43.5% to $127.44 after the company announced positive clinical data for its CRISPR therapy. Marin Software... 
Via Benzinga
News headline image
Mid-Morning Market Update: Markets Mixed; Perion Network Boosts FY21 Outlook ↗
Following the market opening Monday, the Dow traded down 0.30% to 34,329.01 while the NASDAQ rose 0.60% to 14,446.74. The S&P also rose, gaining 0.04% to 4,282.58. The U.S.... 
Via Benzinga
Topics Stocks
News headline image
CEL-SCI's Immunotherapy Achieves Survival Benefit Of 14% Exceeding Pre-Defined 10% In Head & Cancer Patients ↗
CEL-SCI Corporation (NYSE: CVM) has announced results from its Phase 3 study for its immunotherapy Multikine for advanced previously untreated squamous cell... 
Via Benzinga
News headline image
CEL-SCI’s Multikine® Immunotherapy Produces Significant 14.1% 5-Year Survival Benefit (62.7% Vs 48.6%) in the Group Receiving Surgery Plus Radiotherapy in a Landmark Head and Neck Cancer Phase 3 Study
From CEL-SCI Corporation
Via Business Wire
News headline image
24 Stocks Moving in Monday's Pre-Market Session ↗
Gainers Intellia Therapeutics, Inc. (NASDAQ: NTLA) rose 28.9% to $114.49 in pre-market trading. Intellia Therapeutics and Regeneron Pharmaceuticals disclosed positive interim... 
Via Benzinga
News headline image
CEL-SCI Corporation Invites Participants to Pre-Submit Questions for Annual Shareholder Meeting
From CEL-SCI Corporation
Via Business Wire
News headline image
Cel-Sci Stock Shows Market Leadership With Jump To 81 RS Rating ↗
Cel-Sci sees its Relative Strength Rating hit the 80-plus level. 
Via Investor's Business Daily
News headline image
CEL-SCI Announces the Closing of $31.7 Million Bought Deal Offering
From CEL-SCI Corporation
Via Business Wire
News headline image
62 Biggest Movers From Yesterday ↗
Gainers Aethlon Medical, Inc. (NASDAQ: AEMD) shares surged 388.2% to close at $10.79 on Wednesday in reaction to Zacks Article 'AEMD: First Ever In Vivo Removal Of COVID... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.